Benitec Biopharma Inc. Other Non-Current Assets
Benitec Biopharma Inc. (BNTC) had Other Non-Current Assets of $12.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-09-14
- 2026-06-30: Other Assets, Noncurrent $12.00K.
- 2026-03-31: Other Assets, Noncurrent $12.00K.
- 2025-12-31: Other Assets, Noncurrent $11.00K.
- 2025-09-30: Other Assets, Noncurrent $20.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $12.00K 10-K · filed 2026-09-14 |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $11.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $20.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $28.00K 10-K · filed 2026-09-14 |
| 2025-03-31 | $35.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $42.00K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $56.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $62.00K 10-K/A · filed 2026-03-20 |
| 2024-03-31 | $69.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $81.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $85.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $97.00K 10-K · filed 2024-09-26 |
| 2023-03-31 | $105.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $116.00K 10-Q · filed 2023-02-13 |
| 2022-09-30 | $119.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $135.00K 10-K · filed 2023-09-21 |
| 2022-03-31 | $156.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $161.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $169.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $185.00K 10-K · filed 2022-09-02 |
| 2021-03-31 | $197.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $210.00K 10-Q · filed 2021-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |